Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
36.88
0.37 (1.01%)
At close: Aug 15, 2025, 3:59 PM
36.87
-0.03%
After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
453M 311.66M 243.78M 234.31M
Short-Term Investments
14.19M 41.8M 79.33M n/a
Long-Term Investments
108.87M 72.17M 22.57M 750K
Other Long-Term Assets
6.16M 6.57M 3.55M 4.26M
Receivables
83.03M 74.14M 54.74M 34.84M
Inventory
7.2M 5.36M 4.3M 4.43M
Other Current Assets
8.12M 5.54M 8.79M 3.22M
Total Current Assets
579.25M 451.07M 400.29M 284.44M
Property-Plant & Equipment
1.26M 371K 573K 820K
Goodwill & Intangibles
113.26M 137.11M 160.95M 143.92M
Total Long-Term Assets
419.95M 360.38M 273.58M 149M
Total Assets
999.2M 811.45M 673.87M 433.44M
Account Payables
13.74M 17.73M 3.79M 1M
Deferred Revenue
n/a n/a n/a 49.41M
Short-Term Debt
16.25M 15M 2M 2M
Other Current Liabilities
145.09M 107.3M 1.62M 41.61M
Total Current Liabilities
175.08M 163.78M 78.88M 53.77M
Long-Term Debt
163.02M 178.57M 189.65M 189.98M
Other Long-Term Liabilities
164.96M 2.11M 2.5M 3.18M
Total Long-Term Liabilities
164.96M 180.68M 192.15M 193.16M
Total Liabilities
340.05M 344.46M 271.03M 246.94M
Total Debt
179.27M 193.57M 191.65M 191.98M
Common Stock
1K 1K 1K 1K
Retained Earnings
2.22M -143.28M -272.13M -453.6M
Comprehensive Income
66K 2K -151K -0.00
Shareholders Equity
659.15M 466.99M 402.84M 186.51M
Total Investments
123.06M 113.97M 101.9M 750K